ODINK DEBRA 4
4 · Anthera Pharmaceuticals Inc · Filed Jul 3, 2012
Insider Transaction Report
Form 4
ODINK DEBRA
VP, Pharmaceutical R&D
Transactions
- Tax Payment
Common Stock
2012-06-30$0.69/sh−1,838$1,268→ 24,821 total
Holdings
- 95,928(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting Person, which are subject to certain vesting conditions.